Y-Intercept (HK)’s Gossamer Bio GOSS Stock Holding History

Y-Intercept (HK)’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.11K	Buy	+43,210	New	+$12.1K	﹤0.01%	1650
2024 Q2	–	Sell	-90,806	Closed	-$107K	–	1577
2024 Q1	$107K	Buy	+90,806	New	+$100K	0.01%	1273
2023 Q3	–	Sell	-66,064	Closed	-$79.3K	–	1244
2023 Q2	$79.3K	Sell	66,064 -113,658	-63%	-$142K	0.01%	1139
2023 Q1	$226K	Buy	+179,722	New	+$344K	0.03%	902

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Y-Intercept (HK)'s GOSS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Gossamer Bio (GOSS) in Q2 2026: 43,210 shares worth $7.11K. The stake represents ﹤0.01% of the portfolio and ranks #1650 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in GOSS as recently as Q1 2024.

Y-Intercept (HK) first reported a position in GOSS in Q1 2023 and has held it in 4 quarters since. The position peaked at $226K in Q1 2023. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Y-Intercept (HK) held 43,210 shares of Gossamer Bio worth $7.11K as of Q2 2026.
Gossamer Bio was a new Y-Intercept (HK) position in Q2 2026.
Gossamer Bio made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1650 holding.
Y-Intercept (HK) first reported a position in Gossamer Bio in Q1 2023 and has held it in 4 quarters since.
Y-Intercept (HK)'s Gossamer Bio position peaked at $226K in Q1 2023.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.